Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease-Authors' reply

Affiliations

Comment

Melek Simsek et al. Aliment Pharmacol Ther. 2020 Jul.

. 2020 Jul;52(1):216-217.

doi: 10.1111/apt.15806.

¹ Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

No abstract available

Comment on

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.
Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC). Simsek M, et al. Aliment Pharmacol Ther. 2019 May;49(10):1293-1300. doi: 10.1111/apt.15229. Epub 2019 Mar 25. Aliment Pharmacol Ther. 2019. PMID: 30908719 Free PMC article.
Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease.
Lansdorp CA, Buskens CJ, Gecse KB, D'Haens GRAM, van Hulst RA. Lansdorp CA, et al. Aliment Pharmacol Ther. 2020 Jul;52(1):215-216. doi: 10.1111/apt.15775. Aliment Pharmacol Ther. 2020. PMID: 32529770 No abstract available.